Nu Skin Enterprises (NYSE:NUS) Releases FY 2024 Earnings Guidance

Nu Skin Enterprises (NYSE:NUSGet Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 0.650-0.750 for the period, compared to the consensus earnings per share estimate of 0.770. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $1.8 billion. Nu Skin Enterprises also updated its Q4 guidance to $0.19 to $0.29 EPS.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on NUS shares. Citigroup dropped their price target on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research note on Tuesday, October 22nd. StockNews.com cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Wednesday, October 23rd. Finally, DA Davidson decreased their price target on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating for the company in a research report on Monday, August 12th.

View Our Latest Research Report on NUS

Nu Skin Enterprises Stock Performance

Shares of NYSE:NUS traded up $0.10 during midday trading on Friday, hitting $6.55. The company had a trading volume of 991,684 shares, compared to its average volume of 751,884. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 1.33. The company has a fifty day moving average of $6.85 and a two-hundred day moving average of $9.87. The company has a market cap of $325.54 million, a price-to-earnings ratio of -2.20 and a beta of 1.14. Nu Skin Enterprises has a 12-month low of $5.95 and a 12-month high of $20.75.

Nu Skin Enterprises (NYSE:NUSGet Free Report) last posted its earnings results on Thursday, August 8th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.04. Nu Skin Enterprises had a negative net margin of 8.05% and a positive return on equity of 7.80%. The business had revenue of $439.10 million for the quarter, compared to analyst estimates of $431.87 million. During the same period in the prior year, the company posted $0.54 EPS. The company’s revenue for the quarter was down 12.2% on a year-over-year basis. On average, equities research analysts expect that Nu Skin Enterprises will post 0.78 EPS for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 11th. Stockholders of record on Friday, November 29th will be issued a $0.06 dividend. The ex-dividend date is Friday, November 29th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.66%. Nu Skin Enterprises’s payout ratio is -8.05%.

Nu Skin Enterprises Company Profile

(Get Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Read More

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.